1 completed, 1 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Arrow Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the PK, Safety and Antiviral Activity of A-831 in HCV Carriers A-831 - Chronic Hepatitis C | Phase 1 / Phase 2 | Terminated | Arrow Therapeutics | 36 | 2007-08-01 | 2008-09-29 |
| A Study of the Safety and Efficacy of A-60444 in Adults With Respiratory Syncytial Virus (RSV) Infection Following HSCT A-60444 - Respiratory Syncytial Virus Infections | Phase 2 | Completed | Arrow Therapeutics | 27 | 2005-09-01 | 2010-02-12 |
Hepatitis C, Chronic (1) · Respiratory Syncytial Virus Infections (1)
United Kingdom (2) · New Zealand (1)
Brian Sanderson (1) · David Mutimer (1) · Edward Gane (1) · Stephen MacKinnon (1)